CAES Cantor Equity Partners VII, Inc.
Executive Summary
Cantor Equity Partners VII, Inc. filed Amendment No. 2 to its S-1 registration statement for an IPO of 25 million Class A ordinary shares at $10 per share, targeting $250 million in gross proceeds. As a blank-check SPAC with no operations, it will use the trust proceeds to acquire a target business within 24 months. This amendment updates the prospectus but does not materially change the offering structure or risk profile.
Key Financial Metrics
Actionable Insight
Monitor for the effective date of the IPO and subsequent trading of CAES. The SPAC has 24 months to announce a target; track any 8-K filings or press releases regarding a business combination agreement. The stock will likely trade near the $10 trust value until a deal is announced.
Key Facts
- Offering of 25,000,000 Class A ordinary shares at $10.00 per share, targeting $250,000,000 in gross proceeds.
- Underwriters have a 45-day option to purchase up to an additional 3,750,000 shares to cover over-allotments.
- Sponsor will purchase 600,000 private placement shares at $10.00 per share ($6,000,000 aggregate) simultaneously with the IPO closing.
- Sponsor purchased 7,187,500 Class B founder shares for $25,000 (approx. $0.003 per share); up to 937,500 are subject to forfeiture depending on over-allotment exercise.
- Company has 24 months from the closing of the offering to consummate an initial business combination or will liquidate and redeem public shares.
- Proceeds of $250,000,000 (or $287,500,000 if over-allotment exercised in full) will be deposited into a trust account.
- Company has no operations and has not identified any business combination target.
- Net tangible book value per share after the offering is estimated at $7.57 (assuming no redemptions and no over-allotment).
Financial Impact
IPO targeting $250 million in gross proceeds; sponsor invests $6 million in private placement; founder shares purchased for $25,000.
Risk Factors
- No identified acquisition target; risk of liquidation if no deal within 24 months.
- Significant dilution to public shareholders from founder shares purchased at nominal price.
- Conflicts of interest with sponsor and affiliates, including other Cantor-sponsored SPACs competing for targets.
- Potential inability to complete a business combination due to market conditions or redemptions.
- Risk of being deemed an investment company under the Investment Company Act.
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001213900-26-066499 |
| Document: ea026170705ex1-1.htm | 0001213900-26-066499 |
| Document: ea026170705ex10-3.htm | 0001213900-26-066499 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
4d ago
|
S-1/A
| — | awaiting T+20 | — | — |
|
Jun 2, 2026
10d ago
|
S-1/A
| — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access